Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) shares were down 0.3% during mid-day trading on Friday . The stock traded as low as C$6.21 and last traded at C$6.21. Approximately 30,927 shares traded hands during mid-day trading, an increase of 317% from the average daily volume of 7,410 shares. The stock had previously closed at C$6.23.
Eupraxia Pharmaceuticals Trading Down 2.0%
The business has a fifty day moving average price of C$6.03 and a 200 day moving average price of C$5.41.
About Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.
Further Reading
- Five stocks we like better than Eupraxia Pharmaceuticals
- Best Stocks Under $10.00
- Dave & Buster’s Reversal Is in PLAY After Double-Bottom Breakout
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- Upcoming IPO Stock Lockup Period, Explained
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
